Johnson & Johnson Innovation
CVC
Active
New Brunswick, United States
81
31M
65
1.59
16
0.19
11
- Areas of investment
Summary
The main department of described VC is located in the New Brunswick. The company was established in North America in United States. Johnson & Johnson Innovation appeared to be a CVC structure as part of the corporation.
The top activity for fund was in 2016. The higher amount of exits for fund were in 2019. Opposing the other organizations, this Johnson & Johnson Innovation works on 16 percentage points less the average amount of lead investments. The fund is generally included in 7-12 deals every year. The average startup value when the investment from Johnson & Johnson Innovation is more than 1 billion dollars. The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Johnson & Johnson Innovation, startups are often financed by Johnson & Johnson Development Corporation, Novartis Venture Fund, Sanderling Ventures. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Pfizer Venture Investments, ARCH Venture Partners. In the next rounds fund is usually obtained by Innovate UK, W.L. Gore & Associates, Vertex Ventures HC.
The overall number of key employees were 8.
Among the most popular fund investment industries, there are Medical, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Carbon3D, Merus, Fusion Pharmaceuticals. The fund has exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 81
- Lead investments
- 16
- Exits
- 11
- Rounds per year
- 1.59
- Follow on index
- 0.19
- Investments by industry
- Biotechnology (60)
- Health Care (56)
- Medical (26)
- Therapeutics (23)
- Medical Device (23) Show 37 more
- Investments by region
-
- United States (52)
- Israel (10)
- United Kingdom (5)
- France (2)
- Netherlands (1) Show 6 more
- Peak activity year
- 2016
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Avg. valuation at time of investment
- 39M
- Group Appearance index
- 0.83
- Avg. company exit year
- 8
- Avg. multiplicator
- 0.89
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Moon Surgical | 07 Jun 2022 | Health Care, Medical Device | Early Stage Venture | 31M | Ile-de-France, Paris, France |
| Moon Surgical | 17 May 2023 | Health Care, Medical Device | Early Stage Venture | 55M | Ile-de-France, Paris, France |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.